Dry Age-related Macular Degeneration Clinical Trials
3 recruiting trials for Dry Age-related Macular Degeneration. Eligibility criteria explained in plain English.
3
Total Trials
3
Recruiting Now
1
Phase 3 Trials
3
Sponsors
Recruiting Trials
RECRUITINGPhase 2NCT06557460
A Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy)
This is a Phase IIb randomized, clinical trial designed to assess the safety and efficacy of unilateral implantation of the CPCB-RPE1 implant in subjects with geographic atrophy...
Sponsor: Regenerative Patch Technologies, LLCEnrolling: 245 locations
RECRUITINGPhase 1 / Phase 2NCT04339764
Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy...
Background: Age-related macular degeneration is a common eye disease in people over 50. The "dry" form of the disease can worsen into geographic atrophy, causing blind spots....
Sponsor: National Eye Institute (NEI)Enrolling: 202 locations
RECRUITINGPhase 3NCT06165068
Effects of Antiplatelet and Antioxidant Agents on Drusen Progression: A Pilot, Prospective Cohort Study
The aim of this clinical trial is to evaluate the effect of low doses of antiplatelet medications (aspirin 81 mg/day or clopidogrel 75 mg/day) with or without a combination of...
Sponsor: Navamindradhiraj UniversityEnrolling: 1741 location